An equity transfer signing ceremony is held between SDIC Innovation Institutes and Dongsheng Biotech (Taixing). [Photo/WeChat account: gh_07a864197818]
SDIC Innovation Institutes, a subsidiary of State Development & Investment Corp (SDIC), signed an equity transfer agreement with Dongsheng Biotech (Taixing), located in the Taixing Huangqiao Economic Development Zone, Taixing, Jiangsu province, and started the new protein industrialization project on Dec 16.
The former is a powerful national capital, while the latter is a private "little giant" with a 60 percent market share in its segment.
This cooperation signifies the creation of a comprehensive "technology R&D plus industrial commercialization" chain in new protein development. It also provides significant momentum to the biomanufacturing sector's strategic emerging industry through cooperation between central and local authorities.
New protein is one of the most important components of biomanufacturing — the food sector. It is all edible protein produced without relying on traditional animal farming or fishing methods, representing an innovative model for efficient edible protein production through advanced biotechnology.
Dongsheng is a worldwide leader in TG enzyme manufacturing, exporting its main products to more than 40 countries and regions, and holding a 60 percent share of the domestic market.
Following the signing of the new protein project, Dongsheng's original fermentation workshop can be directly utilized for this project. Its compounding workshop can also maintain production capacity via line modifications and expansions.
"The fungal protein project is beyond the scope of Dongsheng, a relatively small private company, to execute alone. SDIC has a long-term strategic plan and actual investments, and we are open to collaborating," said Wang Hao, executive deputy general manager of Dongsheng.